Clay Siegall cofounded Seattle Genetics in 1988 and is currently the President, CEO and a sits on the company’s board as a member of its directors. The company leads in innovation in antibodies technology and has made a drug; an antibody conjugate known as ADC. Dr. Siegall has led Seattle Genetics’ capital raising campaign, helping the company amass funds amounting to over US $330 million via private and public financing taking into account the firm’s 2001 initial public offering. Seattle Genetics has as well made deals with several key organizations, for instance, the company has entered into an $860 million deal for SGN-40 with Genentech, Bayer, and Progenics, CuraGen, and MedImmune. Since 2001, the company’s involvement with the named companies has raised about 65 million dollars.

Education and Work Experience

Before he cofounded Seattle Genetics, Clay Siegall worked for National Institutes of Health and the National Cancer Institute from 1988-1991. From 1991 to 1997, Dr. Siegall used to work for the Bristol-Myers Squibb Pharmaceutical Research Institute. He has a Bachelor of Science degree in Zoology from the University of Maryland and a Ph.D. in Genetics from George Washington University. He serves on the Board of Governors of the Fred Hutchinson Cancer Research Business Alliance, the Washington Biotechnology and Biomedical Association (WBBA) as well as the Alder Biopharmaceuticals’ Board of Directors.

Fight against Cancer

Seattle Genetics is targeting different strains of autoimmune and cancer symptoms using its many assortments of experimental cancer drugs it’s developing. At the moment, Seattle Genetics is developing more than ten cancer drugs. One of these drugs which go by 33A will be used to treat acute myeloid leukemia, and it is in the third stage of clinical analysis. The company has also reported that it is in the final stages of development of a breast and bladder cancer drugs. Also, Seattle Genetics is conducting innovative clinical research for a Hodgkin lymphoma drug called Adcetris. The drug will be used to treat the condition if detected in its early stages. Previously, there was no cure for Hodgkin lymphoma whatsoever.

Journalists at Pacific Northwest Research Institute Newsroom describes meeting Dr. Clay Siegall as a one of a kind ‘learning’ experience.

Learn more about Clay Siegall:

The Midas Legacy is offering individuals a new way to improve their lives and achieve happiness. Many people face problems when it comes to managing their lives and pursuing their dreams and aspirations. Failures that occur in life lead to frustrations and in some extreme conditions depression.

All these problems can be avoided if one works with The Midas Legacy through their program that is meant to address all the worries and challenges that come in life. The company works with highly experienced professionals who provide professional support services that are tailored to meet the needs of their clients.

For example, The Midas Legacy helps entrepreneurs to plan their ideas well and to manage finances and other roles that can make their businesses better. They have a team that offers wealth and financial advisory services that are targeted at enhancing the performance of an individual or business. The overall effect of working with The Midas Legacy is achieving total success and happiness in life. The company has grown its network over the past few years due to the many success stories they have helped to write.


Individual health is also part of the issues The Midas Legacy reviews and the professionals ensure one is issued advice that can help them to choose the right diet. Through the natural cures program, one is able to learn about the right foods and methods of dinning that can improve their feeling and health. The Midas Legacy offers solutions that are also meant to cure many types of diseases using the same program.

Retirement and savings advice


Additionally, The Midas Legacy provides individuals with savings and retirement planning advice that helps them to secure their future. At retirement, few are able to come up with a good plan for their life after employment or work. Savings is also a part of life that one should take seriously, but planning on savings is a bit of a challenge to many people, reason The Midas Legacy addresses this topic with great emphasis.

The Midas Legacy
For success advisory and to eliminate problems in life that could lead to frustrations, The Midas Legacy is the right channel to follow. This is a company that works with people who are looking to improve their lives and achieve success through changes in different aspects of life. The company works with investors who are after improving their money management skills.

An effort to repatriate Native American human remains that were disinterred as part of archaeological excavations will continue this week when a Harvard museum transfers 98 individuals to the Saginaw Chippewa Indian Tribe of Michigan and other tribes.

The ancestral remains were part of the holdings of Harvard University’s Peabody Museum of Archaeology and Ethnology in Boston. They have been identified as coming from seven different counties in Michigan and one unidentified site. Five other Native American groups have connections to the human remains, including the Ottawa and Potawatomi tribes.

A delegation of representatives from the Saginaw Chippewa Tribe was set to travel to Boston to receive the human relics, some of which have been at the museum since 1869.

Fifty-one individuals will be reburied at the Nibokaan Ancestral Cemetery on the Saginaw Chippewa’s Isabella Indian Reservation. A public Recommitment to the Earth Ceremony will be held, followed by a Journey Feast at the Ziibiwing Center of Anishinabe Culture and Lifeways in Mount Pleasant, Michigan.

The additional 47 remains will be reburied at sites within the territories of the five other tribes that have been identified as the proper recipients. Peabody Museum is assisting in the repatriation.

The Native American Graves Protection and Repatriation Act of 1990 calls for the identification of ancestral remains in museums and institutions across the country and their reburial on tribal lands. So far, 10,000 remains and more than 1 million funerary and sacred artifacts have been returned under the Act.